제넨바이오 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 엠씨제2호그로우쓰사모투자, was filed 09 Jan 2024.
제넨바이오: what insiders have been doing
제넨바이오 is a Health Care company. Its directors and officers file their transactions with DART (FSS). The past year has been quiet: not a single insider filing for 제넨바이오. The previous disclosure was published on 14 March 2024.
Other companies in the same sector with recent insider buying flagged by our signals: Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Financial data
· cache
- ●Executives0DART
- 13,231,308 sharesKRXDART:20240213000973
- 17,000,000 sharesShareKRXDART:20240109000104Canonical exit: 10 Mar 2024 (T+90)
- 14,690,218 sharesKRXDART:20240109000100Canonical exit: 10 Mar 2024 (T+90)
- 5,660,331 sharesKRXDART:20231130001566Canonical exit: 30 Jan 2024 (T+90)
- 11,169,024 sharesShareKRXDART:20230412000354Canonical exit: 3 Jul 2023 (T+90)
- 11,169,024 sharesKRXDART:20230412000401Canonical exit: 11 Jul 2023 (T+90)
- 625,000 sharesKRXDART:20230331003441
- ●Executives0DART
- 870,981 sharesKRXDART:20230310000747
- 843,660 sharesKRXDART:20230309000016
- 522,473 sharesKRXDART:20230110000545
- 22,324,263 sharesKRXDART:20221209000456
- 9,589,431 sharesKRXDART:20220930000578Canonical exit: 29 Dec 2022 (T+90)
- 973,051 sharesKRXDART:20220923000339
- 533,109 sharesKRXDART:20220810000281Canonical exit: 8 Nov 2022 (T+90)
- 3,648,159 sharesShareKRXDART:20220808000215
- 2,458,396 sharesKRXDART:20220405002437Canonical exit: 4 Jul 2022 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
25 of 38 declarations
About 제넨바이오
Genenbio is in the healthcare and pharmaceutical sector, listed on the XKRX market. The company focuses on developing innovative biopharmaceutical solutions.
